Company intelligence
Astex Pharmaceuticals
Committed to the fight against cancer and CNS disorders
About Astex Pharmaceuticals
Astex Pharmaceuticals is a world leader in innovative drug discovery. Our research teams utilize a cutting edge technology platform in the relentless pursuit of innovative solutions that address the extensive and complex challenges in oncology and diseases of the CNS. The company has successfully applied its proprietary Fragment-Based Drug Discovery (FBDD) platform to generate multiple new drug candidates that are progressing in clinical development. Successful collaborations with Pharma partners have led to three launched oncology drugs (Kisqali® partnered with Novartis, Balversa® partnered with Janssen and Truqap™ from AstraZeneca). Astex continues to grow in Cambridge, UK and has opportunities for experienced and innovative scientists wishing to develop their careers in a thriving multidisciplinary, industrial environment. For more information about Astex or for job opportunities, please visit our website below.
Verified activity
Signals from Astex Pharmaceuticals
4 published signals
Presence & Recognition
Astex Pharmaceuticals was selected as a finalist in the European Lifestars Awards in the Licensing Deal of the Year (up to €500m) category.
Reported by Astex Pharmaceuticals
Partnerships
Astex Pharmaceuticals announced a worldwide research collaboration and licence agreement with Genentech, a member of the Roche Group announced in July.
Reported by Astex Pharmaceuticals
People
Astex Pharmaceuticals is hiring a new Cell Biologist in Cambridge, England.
Reported by Astex Pharmaceuticals
People
Astex Pharmaceuticals is hiring a Cell Biologist in Cambridge, England.
Reported by Astex Pharmaceuticals